Global burden of head and neck cancer from 1990 to 2021: A comprehensive analysis and projections to 2030 based on the global burden of disease study 2021
PLOS One · 08.09.2025 · 20 (9) · e0330805
DOI: 10.1371/journal.pone.0330805 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.09.2025. Verfasst von Muling Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Head and Neck Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Province Joint Funds for the Innovation of Science and Technology, Natural Science Foundation of Xiamen Municipality, Fujian Provincial Maternity and Children’s Hospital.
Abstract (Originalsprache)
Background
Head and neck cancer (HNC) is a significant global health concern with rising incidence and mortality in certain regions. This study aimed to evaluate the global burden and temporal trends of HNC from 1990 to 2021 and to project its future burden through 2030.
Methods
Data were obtained from the Global Burden of Disease (GBD) 2021 study. Joinpoint regression was used to assess temporal trends in age-standardized incidence rates (ASIR), age-standardized death rates (ASDR), and disability-adjusted life years (DALYs). Age–period–cohort (APC) and Bayesian APC (BAPC) models were applied to evaluate age, period, and cohort effects and to project future trends. Decomposition analysis was conducted to explore the contributions of population aging, growth, and epidemiological changes.
Results
In 2021, there were 792,280 new HNC cases and 424,066 deaths globally. Age-standardized incidence rates remained stable, while death rates and DALYs significantly declined. Incidence rose notably in East Asia, whereas mortality and DALYs increased substantially in Oceania. Gender differences were evident, with higher burdens in males, although female incidence rates recently increased. Aging and population growth were key contributors to the rising burden. Projections suggest a notable increase in female incidence and continued decline in male DALYs by 2030. Among HNC subtypes, lip and oral cavity cancers had the highest burden, whereas other pharyngeal cancers showed increasing incidence trends.
Conclusions
Despite overall declines in mortality and disease burden, the global incidence of HNC remains substantial. Targeted interventions—such as tobacco and alcohol control and widespread HPV vaccination—are essential to mitigate the future burden of HNC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
ORCID-Profile: Jianming Ding
Förderung
- Fujian Province Joint Funds for the Innovation of Science and Technology
- Natural Science Foundation of Xiamen Municipality
- Fujian Provincial Maternity and Children’s Hospital
- Intramural Research Fund of Fujian Cancer Hospital
Zitieren
APA
Deng, M., Lin, Y., Yan, L., Fei, Z., Chen, C., & Ding, J. (2025). Global burden of head and neck cancer from 1990 to 2021: A comprehensive analysis and projections to 2030 based on the global burden of disease study 2021. PLOS One, 20(9), e0330805. https://doi.org/10.1371/journal.pone.0330805
Vancouver
Deng M, Lin Y, Yan L, Fei Z, Chen C, Ding J. Global burden of head and neck cancer from 1990 to 2021: A comprehensive analysis and projections to 2030 based on the global burden of disease study 2021. PLOS One. 2025;20(9):e0330805. doi:10.1371/journal.pone.0330805
BibTeX
@article{Deng2025,
author = {Deng, Muling and Lin, Yuhao and Yan, Linghui and Fei, Zhaodong and Chen, Chuanben and Ding, Jianming},
title = {Global burden of head and neck cancer from 1990 to 2021: A comprehensive analysis and projections to 2030 based on the global burden of disease study 2021},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {9},
pages = {e0330805},
doi = {10.1371/journal.pone.0330805}
}
EUVIMED